What Are Proven Defense Strategies in Opioid Fraud Investigations
The strategies that produce the best outcomes in DEA opioid fraud investigations are not primarily courtroom strategies. They are pre-indictment strategies, built from the records, the clinical documentation, and the expert analysis that distinguish legitimate prescribing from diversion.
The most successful defense outcomes in opioid fraud cases, the declinations, the administrative resolutions without criminal prosecution, and the acquittals at trial, share a common feature: they present the government with a specific, documented, credible account of why the prescribing was medically appropriate. The government’s case is built on data. The defense is built on clinical context. The outcome depends on whether the clinical context is sufficiently documented and credibly presented to reframe the data.
The Medical Records Defense
The foundation of every legitimate prescribing defense is the medical record. A practitioner who documented each patient encounter thoroughly, who recorded the examination findings, the clinical assessment, the treatment rationale, and the prescription decision contemporaneously, has created the evidentiary foundation for a defense that the data alone cannot defeat. The PDMP may show that the practitioner prescribed more opioids than their peers. The medical records may show why: a patient population with higher rates of chronic pain conditions, more complex comorbidities, or greater needs than the population the peer comparison reflects.
The medical records review, conducted early in the representation by counsel and by a retained medical expert, produces an assessment of the quality of the clinical documentation and its ability to support the prescribing decisions it reflects. Where the records are strong, the defense strategy is built around them. Where the records have gaps, the strategy must address those gaps before the government identifies them as evidence of prescribing without clinical basis.
The Medical Expert
In every opioid fraud case that reaches the point of government charging consideration, the contest is between competing assessments of whether the prescribing met the standard of care for legitimate medical practice. The government has experts. The defense needs experts. The retained medical expert who can review the prescribing records, assess the clinical documentation, and provide a credible opinion that the prescribing was within acceptable medical practice is the defense’s most consequential resource.
The medical expert’s role is not limited to trial testimony. In the pre-indictment phase, the expert’s analysis is the basis for the written submission to the prosecuting attorney’s office that presents the defense’s clinical argument. That submission, prepared by counsel and supported by the expert’s analysis, may persuade the government to decline prosecution or to significantly narrow the charges. The same expert who prepared the pre-indictment analysis is positioned to testify at trial if the case proceeds.
The selection of the medical expert is a decision that requires care. An expert with national recognition in pain management, with specific experience in the clinical standards applicable to the prescribing at issue, and with the ability to communicate complex clinical concepts to a jury is a different asset than a local physician who agrees with the prescribing but who cannot withstand the cross-examination a federal prosecutor will conduct. The government’s experts are experienced in this specific context. The defense expert must be too.
Need Help With Your Case?
Don't face criminal charges alone. Our experienced defense attorneys are ready to fight for your rights and freedom.
- 100% Confidential
- Response Within 1 Hour
- No Obligation Consultation
Or call us directly:
(212) 300-5196Pre-Indictment Engagement
The pre-indictment period, between the investigation’s first signal and any formal charge, is the period in which the defense has the most ability to affect the government’s charging decision. Counsel who engages the prosecuting attorney’s office during this period can present the clinical documentation, the expert analysis, and the legal arguments that distinguish the specific case from the typical opioid fraud prosecution. The government’s willingness to consider those arguments varies by office, by case, and by the strength of the evidence they have assembled, but the opportunity exists in every case where counsel is retained early enough to pursue it.
Proffer sessions, written submissions to the prosecuting office, and in appropriate cases voluntary cooperation with specific aspects of the investigation are tools available in the pre-indictment period that are either unavailable or less effective after an indictment is returned. Using them requires counsel who has assessed the strength of the defense position and who can present it credibly to an audience that has spent months building the opposite case.
The Ruan Defense
The Supreme Court’s 2022 decision in Ruan v. United States significantly strengthened the good faith defense available to practitioners charged with prescribing outside the usual course of professional practice. Ruan held that the government must prove beyond a reasonable doubt that the defendant subjectively knew they were acting outside the usual course of professional practice or without a legitimate medical purpose. The prior objective standard, which asked what a reasonable physician would have done, has been replaced by a standard that focuses on the defendant’s actual state of mind.
A practitioner who genuinely believed their prescriptions were medically appropriate, who documented that belief contemporaneously through patient records, who consulted available clinical guidelines, and who sought specialist input when the clinical situation warranted it has a strong good faith defense under Ruan. The documentation of the belief is as important as the belief itself, because the jury must be persuaded that the belief was genuine and not post-hoc rationalization.
Todd Spodek
Lead Attorney & Founder
Featured on Netflix's "Inventing Anna," Todd Spodek brings decades of high-stakes criminal defense experience. His aggressive approach has secured dismissals and acquittals in cases others deemed unwinnable.
The defense that succeeds in an opioid fraud case typically does so not by challenging the government’s data but by contextualizing it. The prescribing volume that looks like evidence of a pill mill to a DEA analyst may look like evidence of a dedicated pain management practice to a jury that has heard from the patients whose pain was treated, reviewed the medical records that documented their conditions, and received the testimony of a credible medical expert who explained why the prescribing was clinically appropriate.
The Jury and the Clinical Narrative
Federal juries in opioid fraud cases are composed of citizens who have likely been affected, directly or through someone they know, by the opioid crisis. They arrive at the courtroom with a preformed narrative about pill mills and predatory prescribers. The defense’s task is to replace that narrative with a different one: the narrative of a physician who treated real patients with real pain, who made clinical judgments that were documented and defensible, and who did not recognize themselves in the government’s characterization of their practice.
That narrative requires evidence. It requires patients who can testify about their conditions and their treatment. It requires medical records that support rather than undermine the clinical account. It requires an expert who can explain the clinical standards and the practitioner’s compliance with them. And it requires a defendant who is a credible, humanized presence before the jury, someone whose manner and testimony support rather than contradict the narrative counsel has constructed. Building all of that requires time, preparation, and a defense strategy that begins at the moment counsel is retained.
